These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
89 related items for PubMed ID: 7858548
1. Failure of ribavirin to clear adenovirus infections in T cell-depleted allogeneic bone marrow transplantation. Hromas R, Clark C, Blanke C, Tricot G, Cornetta K, Hedderman A, Broun ER. Bone Marrow Transplant; 1994 Oct; 14(4):663-4. PubMed ID: 7858548 [No Abstract] [Full Text] [Related]
2. Oral ribavirin for severe adenovirus infection after allogeneic marrow transplantation. Abe S, Miyamura K, Oba T, Terakura S, Kasai M, Kitaori K, Sasaki T, Kodera Y. Bone Marrow Transplant; 2003 Dec; 32(11):1107-8. PubMed ID: 14625585 [No Abstract] [Full Text] [Related]
3. Fulminant adenovirus hepatitis following unrelated bone marrow transplantation: failure of intravenous ribavirin therapy. Chakrabarti S, Collingham KE, Fegan CD, Milligan DW. Bone Marrow Transplant; 1999 Jun; 23(11):1209-11. PubMed ID: 10382964 [Abstract] [Full Text] [Related]
4. Adenovirus pneumonitis successfully treated with intravenous ribavirin. Jurado Chacón M, Hernández Mohedo F, Navarro Marí JM, Ferrer Chaves C, Escobar Vedia JL, de Pablos Gallego JM. Haematologica; 1998 Dec; 83(12):1128-9. PubMed ID: 9949635 [Abstract] [Full Text] [Related]
5. Adenovirus-associated haemorrhagic cystitis after bone marrow transplantation successfully treated with intravenous ribavirin. Jurado M, Navarro JM, Hernández J, Molina MA, DePablos JM. Bone Marrow Transplant; 1995 Apr; 15(4):651-2. PubMed ID: 7655400 [No Abstract] [Full Text] [Related]
6. Successful ribavirin therapy for severe adenovirus hemorrhagic cystitis after allogeneic marrow transplant from close HLA donors rather than distant donors. Miyamura K, Hamaguchi M, Taji H, Kanie T, Kohno A, Tanimoto M, Saito H, Kojima S, Matsuyama T, Kitaori K, Nagafuji K, Sato T, Kodera Y. Bone Marrow Transplant; 2000 Mar; 25(5):545-8. PubMed ID: 10713633 [Abstract] [Full Text] [Related]
7. Intravenous ribavirin therapy for adenovirus cystitis after allogeneic bone marrow transplantation. Cassano WF. Bone Marrow Transplant; 1991 Mar; 7(3):247-8. PubMed ID: 2059760 [Abstract] [Full Text] [Related]
8. High incidence of adeno- and polyomavirus-induced hemorrhagic cystitis in bone marrow allotransplantation for hematological malignancy following T cell depletion and cyclosporine. Childs R, Sanchez C, Engler H, Preuss J, Rosenfeld S, Dunbar C, van Rhee F, Plante M, Phang S, Barrett AJ. Bone Marrow Transplant; 1998 Nov; 22(9):889-93. PubMed ID: 9827817 [Abstract] [Full Text] [Related]
9. A new marrow T cell depletion method using anti-CD6 monoclonal antibody-conjugated magnetic beads and its clinical application for prevention of acute graft-vs.-host disease in allogeneic bone marrow transplantation: results of a phase I-II trial. Sao H, Kitaori K, Kasai M, Shimokawa T, Kato C, Yamanishi H, Ueda R, Morishima Y. Int J Hematol; 1999 Jan; 69(1):27-35. PubMed ID: 10641440 [Abstract] [Full Text] [Related]
10. Allogeneic cell-mediated immunotherapy using donor lymphocytes for prevention of relapse in patients treated with allogeneic bone marrow transplantation for hematological malignancies. Naparstek E, Nagler A, Or R, Kapelushnik J, Slavin S. Clin Transpl; 1996 Jan; ():281-90. PubMed ID: 9286578 [Abstract] [Full Text] [Related]
11. Celiac disease transmitted by allogeneic non-T cell-depleted bone marrow transplantation. Bargetzi MJ, Schönenberger A, Tichelli A, Fried R, Cathomas G, Signer E, Speck B, Gratwohl A. Bone Marrow Transplant; 1997 Oct; 20(7):607-9. PubMed ID: 9337064 [Abstract] [Full Text] [Related]
12. CD6+ T cell depleted allogeneic bone marrow transplantation from genotypically HLA nonidentical related donors. Soiffer RJ, Mauch P, Fairclough D, Alyea E, Anderson K, Fisher D, Freedman A, Bartlett-Pandite L, Robertson M, Schlossman R, Gollob J, Marcus K, Murray C, Kuhlman C, Freeman A, Nadler L, Ritz J. Biol Blood Marrow Transplant; 1997 Apr; 3(1):11-7. PubMed ID: 9209736 [Abstract] [Full Text] [Related]
13. T cell-depleted allogeneic bone marrow transplantation for high-risk non-Hodgkin's lymphoma: clinical and molecular follow-up. Juckett M, Rowlings P, Hessner M, Keever-Taylor C, Burns W, Camitta B, Casper J, Drobyski WR, Hanson G, Horowitz M, Lawton C, Margolis J, Peitryga D, Vesole D. Bone Marrow Transplant; 1998 May; 21(9):893-9. PubMed ID: 9613781 [Abstract] [Full Text] [Related]
14. A retrospective Dutch study comparing T cell-depleted allogeneic blood stem cell transplantation vs T cell-depleted allogeneic bone marrow transplantation. Cornelissen JJ, Fibbe WE, Schattenberg AV, Petersen EJ, Willemze R, de Witte TJ, Löwenberg B, Verdonck LF, vd Biezen A, Brand R. Bone Marrow Transplant; 1998 Jun; 21 Suppl 3():S66-70. PubMed ID: 9712499 [Abstract] [Full Text] [Related]
15. Adenovirus infections in adult recipients of blood and marrow transplants. La Rosa AM, Champlin RE, Mirza N, Gajewski J, Giralt S, Rolston KV, Raad I, Jacobson K, Kontoyiannis D, Elting L, Whimbey E. Clin Infect Dis; 2001 Mar 15; 32(6):871-6. PubMed ID: 11247710 [Abstract] [Full Text] [Related]
17. Cytomegalovirus and adenovirus infections and diseases among 75 paediatric unrelated allogeneic bone marrow transplant recipients. Morfin F, Boucher A, Najioullah F, Bertrand Y, Bleyzac N, Poitevin-Later F, Bienvenu F, Simonet V, Galambrun C, Philippe N, Aymard M, Thouvenot D, Souillet G. J Med Virol; 2004 Feb 15; 72(2):257-62. PubMed ID: 14695667 [Abstract] [Full Text] [Related]